Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung

被引:33
作者
Berge, G
Mollerup, S
Ovrebo, S
Hewer, A
Phillips, DH
Eilertsen, E
Haugen, A
机构
[1] Natl Inst Occupat Hlth, Dept Toxicol, N-0033 Oslo, Norway
[2] Canc Res Inst, Sect Mol Carcinogenesis, Surrey SM2 5NG, England
关键词
adducts; cytochrome P450; estrogen receptor; lung cancer; polycyclic aromatic hydrocarbons;
D O I
10.1016/j.lungcan.2004.02.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiological and biochemical studies have indicated that females may be at greater risk of smoking associated lung cancer compared with mates. Among lung cancer patients, female smokers have been found to have higher levels of PAH-related DNA adducts and CYP1A1 gene expression in their normal lung tissue compared to mate smokers. A possible rote of steroid hormones in these sex differences via interactions between aryl. hydrocarbon receptor and estrogen receptor mediated cellular effects has been suggested. In the present study the impact of the estrogen receptor (ERalpha) on CYP1A1 and CYP1B1 gene expression was studied in vitro in human bronchial epithelial. cells. Transient transfection of the BEP2D cell tine with ERalpha influenced neither constitutive expression of CYP1A1 or CYP1B1 nor induction of these genes by TCDD as measured by real-time RT-PCR. ERalpha had no effect on the constitutive or TCDD-induced enzymatic activity of CYP1A1 (EROD). We also studied the effect of steroid hormones on lung PAH metabolic activation in A/J mice. Intact and ovariectomized female mice were orally exposed to a single dose of benzo[alpha]pyrene. Ovariectomy did not influence the levels of either benzo[alpha]pyrene-derived protein or DNA adducts in the lung tissue measured by HPLC and P-32-postlabeling, respectively. In conclusion, the present data do not support the hypothesis of a role of estrogen or the ERalpha in regulating the metabolic activation of polycyclic aromatic hydrocarbons in lung. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 44 条
[1]   RISK OF CANCER IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY [J].
ADAMI, HO ;
PERSSON, I ;
HOOVER, R ;
SCHAIRER, C ;
BERGKVIST, L .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :833-839
[2]   Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status [J].
Angus, WGR ;
Larsen, MC ;
Jefcoate, CR .
CARCINOGENESIS, 1999, 20 (06) :947-955
[3]   SMOKING AND PERIPHERAL TYPE OF CANCER ARE RELATED TO HIGH-LEVELS OF PULMONARY CYTOCHROME-P450IA IN LUNG-CANCER PATIENTS [J].
ANTTILA, S ;
HIETANEN, E ;
VAINIO, H ;
CAMUS, AM ;
GELBOIN, HV ;
PARK, SS ;
HEIKKILA, L ;
KARJALAINEN, A ;
BARTSCH, H .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (05) :681-685
[4]   Estrogen replacement therapy and risk of lung cancer [J].
Blackman, JA ;
Coogan, PF ;
Rosenberg, L ;
Strom, BL ;
Zauber, AG ;
Palmer, JR ;
Langenberg, P ;
Shapiro, S .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (07) :561-567
[5]   DIFFERENT RESPONSE OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD)-SENSITIVE GENES IN HUMAN BREAST-CANCER MCF-7 AND MDA-MB-231 CELLS [J].
DOHR, O ;
VOGEL, C ;
ABEL, J .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 321 (02) :405-412
[6]  
Engeland A, 1996, INT J CANCER, V68, P39, DOI 10.1002/(SICI)1097-0215(19960927)68:1<39::AID-IJC8>3.3.CO
[7]  
2-0
[8]   COMPARISON OF PULMONARY DNA ADDUCT LEVELS, MEASURED BY P-32 POSTLABELING AND ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY IN LUNG PARENCHYMA OF SMOKERS AND EX-SMOKERS [J].
GENESTE, O ;
CAMUS, AM ;
CASTEGNARO, M ;
PETRUZZELLI, S ;
MACCHIARINI, P ;
ANGELETTI, CA ;
GIUNTINI, C ;
BARTSCH, H .
CARCINOGENESIS, 1991, 12 (07) :1301-1305
[9]   Tobacco smoke carcinogens and lung cancer [J].
Hecht, SS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) :1194-1210
[10]   Hormonal carcinogenesis [J].
Henderson, BE ;
Feigelson, HS .
CARCINOGENESIS, 2000, 21 (03) :427-433